Elisa Heyrman
Postdoktor
E-postadress: elisa.heyrman@ki.se
Besöksadress: Alfred Nobels allé 8, 14152 Huddinge
Postadress: H5 Laboratoriemedicin, H5 Klinisk Fysiologi Gustafsson, 141 52 Huddinge
Del av:
- Institutionen för laboratoriemedicin
- Avdelningen för Klinisk fysiologi vid Labmed
Artiklar
- Journal article: NATURE COMMUNICATIONS. 2019;10(1):3288Geeurickx E; Tulkens J; Dhondt B; Jan VD; Lippens L; Vergauwen G; Heyrmari E; De Sutter D; Gevaert K; Impens F; Miinalainen I; Van Bockstal P-J; De Beer T; Wauben MHM; Nolte-'t-Hoen ENM; Bloch K; Swinnen JV; van der Pol E; Nieuwland R; Braems G; Callewaert N; Mestdagh P; Vandesompele J; Denys H; Eyckerman S; De Wever O; Hendrix A
Alla övriga publikationer
- Conference publication: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. 2024;20:87-88Rundqvist H; Joernaker G; Clauss D; Trevaskis M; Hiensch AE; Schmidt ME; Monninkhof EM; Zimmer P; Belloso J; Heyrman E; Gonzalo RF; Wiskemann J; Mueller J; Altena R; Mann B; Francis P; Richardson G; Antill Y; White M; Savas P; van der wall E; Aaronson NK; Senkus E; Urruticoechea A; Stuiver MM; Steindorf K; Bloch W; Wengstrom Y; May AM; Zopf EM
- Conference publication: MEDICINE & SCIENCE IN SPORTS & EXERCISE. 2024;56(10S):1110Rundqvist H; Heyrman E; Mandic M; Rullman E; Stromberg A
- Conference publication: MEDICINE & SCIENCE IN SPORTS & EXERCISE. 2024;56(10):1092-1093Rundqvist H; Heyrman E; Mandic M; Rullman E; Stromberg A
Anställningar
- Postdoktor, Laboratoriemedicin, Karolinska Institutet, 2025-2026
- Postdoktor, Laboratoriemedicin, Karolinska Institutet, 2023-2025
Examina och utbildning
- PhD, Oncolytic virotherapy, Development of a recombinant oncolytic Vaccinia virus encoding a SIRPα-Fc fusion protein to enhance innate antitumour immunity, Queen Mary University of London, 2023
- MSc in Biomedical Science, Major cancer, Development and evaluation of a traceable reference material for extracellular vesicles in liquid biopsies, Ghent University, 2018
- BSc in Biomedical Science, Biomedical Science, Ghent University, 2016